Scientists Finally Circumvent Blood Brain Barrier To Treat Glioblastoma. Do Researchers Eventually Rattle The Glioblastoma Cage?
Glioblastoma is one of the deadliest and most aggressive kinds of brain cancer. The blood-brain barrier, which protects the brain from outside chemicals, provides an unexpected benefit for Glioblastoma.
Immunotherapy, a form of cancer medication that boosts the immune system to fight cancer, may have trouble reaching the brain to treat glioblastoma. The narrative, however, does not finish here, and there is hope at the end of the tunnel.
A new study published in the journal Nature on January 15, 2020 discovered that combining vascular endothelial growth factor C, or VEGF-C, with cancer immunotherapy medications can be beneficial in treating brain cancers such as Glioblastoma.
This study's concept may be characterised as sliding immunotherapy into the brain drainage system. Although the brain has no direct waste disposal system, relatively tiny capillaries lining the inside of the skull can collect tissue waste products and discharge them to the lymphatic system. These small veins develop immediately after birth, aided in part by the vascular endothelial growth factor C, or VEGF-C, gene.
Breaching the blood brain barrier will have a significant impact not just on glioblastoma, but also on many other brain illnesses where the blood brain barrier was previously thought to be practically impenetrable.
References:
Comments
Post a Comment